Felicitas Thol

18.2k total citations · 1 hit paper
125 papers, 4.0k citations indexed

About

Felicitas Thol is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Felicitas Thol has authored 125 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Hematology, 57 papers in Molecular Biology and 35 papers in Genetics. Recurrent topics in Felicitas Thol's work include Acute Myeloid Leukemia Research (100 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (27 papers) and Epigenetics and DNA Methylation (20 papers). Felicitas Thol is often cited by papers focused on Acute Myeloid Leukemia Research (100 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (27 papers) and Epigenetics and DNA Methylation (20 papers). Felicitas Thol collaborates with scholars based in Germany, United States and France. Felicitas Thol's co-authors include Arnold Ganser, Michael Heuser, Richard F. Schlenk, Gudrun Göhring, Brigitte Schlegelberger, Jürgen Krauter, Frédérik Damm, Katharina Wagner, Walter Fiedler and Haiyang Yun and has published in prestigious journals such as Nature Communications, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Felicitas Thol

118 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of Relapsed Acute Myeloid Leukemia

2020 195 citations Felicitas Thol, Arnold Ganser profile →

Peers

Countries citing papers authored by Felicitas Thol

Since Specialization

Citations

This map shows the geographic impact of Felicitas Thol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felicitas Thol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felicitas Thol more than expected).

Fields of papers citing papers by Felicitas Thol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felicitas Thol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felicitas Thol. The network helps show where Felicitas Thol may publish in the future.

Co-authorship network of co-authors of Felicitas Thol

This figure shows the co-authorship network connecting the top 25 collaborators of Felicitas Thol. A scholar is included among the top collaborators of Felicitas Thol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felicitas Thol. Felicitas Thol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trial 2025 ·Leukemia ·(unknown), (unknown), Geoffroy Andrieux, (unknown), Gabriele Greve, (unknown), (unknown), (unknown), (unknown), Felicitas Thol, Michael Heuser, Gesine Bug, Martina Crysandt, Andreas Neubauer, Justus Duyster, Hartmut Döhner, Melanie Boerries, Michael Lübbert, Heiko Becker	0
2	Cell‐free DNA for detection and monitoring of extramedullary AML relapse 2025 ·HemaSphere ·(unknown), (unknown), Stephan Bartels, Elisa Schipper, (unknown), (unknown), (unknown), Razif Gabdoulline, (unknown), Elke Dammann, Hans Kreipe, Ulrich Lehmann, Anke K. Bergmann, Nataliya Di Donato, Michael Stadler, Matthias Eder, Arnold Ganser, Florian H. Heidel, Felicitas Thol, Michael Heuser	2
3	Monitoring of CNS involvement in AML using ultrahigh-sensitivity next-generation sequencing of cell-free DNA 2025 ·Blood ·(unknown), (unknown), (unknown), Stephan Bartels, (unknown), (unknown), Ralph T. Kubo, (unknown), (unknown), (unknown), Razif Gabdoulline, Elisa Schipper, Martin Wichmann, Philipp Schwenkenbecher, Franz Felix Konen, Michael Stadler, Arnold Ganser, Florian H. Heidel, Felicitas Thol, Michael Heuser	0
4	The histone-methyltransferase DOT1L cooperates with LSD1 to control cell division in blast-phase MPN 2025 ·Leukemia ·(unknown), (unknown), (unknown), Manoj Kumar Gupta, (unknown), Tamer T. Önder, Birgit Perner, (unknown), Felicitas Thol, Frédérik Damm, Florian H. Heidel, Florian Perner	1
5	Prognostic Impact of Subclinical FLT3-ITD Microclones in Patients with Acute Myeloid Leukemia 2024 ·Blood ·(unknown), Razif Gabdoulline, Rabia Shahswar, Arnold Kloos, Letizia Venturini, (unknown), (unknown), Victoria Panagiota, Michael Stadler, Matthias Eder, Gernot Beutel, Elke Dammann, P Poll, Anke K. Bergmann, Nataliya Di Donato, Florian H. Heidel, Felicitas Thol, Michael Heuser	1
6	Dose-Reduced FLA-IDA in Combination with Venetoclax Is an Effective and Safe Salvage Therapy in Relapsed and Refractory Acute Myeloid Leukemia (R/R AML) 2024 ·Cancers ·(unknown), (unknown), (unknown), Michael Heuser, Felicitas Thol, Francis Ayuk, Christine Wolschke, Evgeny Klyuchnikov, Carsten Bokemeyer, Walter Fiedler, (unknown)	0
7	Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantation 2024 ·Bone Marrow Transplantation ·(unknown), Nico Gagelmann, Rachel B. Salit, Thomas Schroeder, Carmelo Gurnari, Simona Pagliuca, Victoria Panagiota, Christina Rautenberg, Bruno Cassinat, Felicitas Thol, Marie Robin, (unknown), Michael Heuser, Marie‐Thérèse Rubio, Jaroslaw P. Maciejewski, Hans Christian Reinhardt, Bart L. Scott, Nicolaus Kröger	1
8	Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation 2023 ·Blood ·Nico Gagelmann, Anita Badbaran, Rachel B. Salit, Thomas Schroeder, Carmelo Gurnari, Simona Pagliuca, Victoria Panagiota, Christina Rautenberg, Bruno Cassinat, Felicitas Thol, Christine Wolschke, Marie Robin, Michael Heuser, Marie‐Thérèse Rubio, Jaroslaw P. Maciejewski, Hans Christian Reinhardt, Bart L. Scott, Nicolaus Kröger	15
9	Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia 2020 ·Leukemia ·Arnold Kloos, (unknown), (unknown), Razif Gabdoulline, (unknown), Nidhi Jyotsana, (unknown), Renate Schottmann, Michaela Scherr, Charu Gupta, Felix F. Adams, Adrian Schwarzer, Dirk Heckl, Axel Schambach, Suzan Imren, R. Keith Humphries, Arnold Ganser, Felicitas Thol, Michael Heuser	9
10	IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction—a retrospective propensity score analysis 2020 ·Leukemia ·Badder Kattih, (unknown), Piroska Klement, Abel Martin Garrido, Razif Gabdoulline, Alessandro Liebich, (unknown), Anuhar Chaturvedi, Timon Seeger, Felicitas Thol, Gudrun Göhring, Brigitte Schlegelberger, Robert Geffers, David John, Udo Bavendiek, Johann Bauersachs, Arnold Ganser, Joerg Heineke, Michael Heuser	37
11	Newly diagnosed isolated myeloid sarcoma–paired NGS panel analysis of extramedullary tumor and bone marrow 2020 ·Annals of Hematology ·Nils W. Engel, (unknown), (unknown), Victoria Panagiota, Razif Gabdoulline, Felicitas Thol, Michael Heuser, Walter Fiedler	9
12	Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation 2019 ·Blood ·Nico Gagelmann, Markus Ditschkowski, (unknown), Swann Bredin, Marie Robin, Bruno Cassinat, Rabia Shahswar, Felicitas Thol, Michael Heuser, Gèrard Socié, Dietrich W. Beelen, Ioanna Triviai, Anita Badbaran, Nicolaus Kröger	107
13	Synergistic Activity of IDH1 Inhibitor Bay-1436032 with Azacitidine in IDH1 Mutant Acute Myeloid Leukemia 2017 ·Blood ·Anuhar Chaturvedi, Charu Gupta, (unknown), Razif Gabdoulline, Stefan Kaulfuß, Kerstin Görlich, Renate Schottmann, Olaf Panknin, Markus Wagner, Robert Geffers, Arnold Ganser, Felicitas Thol, Michael Jeffers, Andrea Haegebarth, Michael Heuser	8
14	An optimized lentiviral vector system for conditional RNAi and efficient cloning of microRNA embedded short hairpin RNA libraries 2017 ·Biomaterials ·Felix F. Adams, Dirk Heckl, Thomas Hoffmann, Steven R. Talbot, Arnold Kloos, Felicitas Thol, Michael Heuser, Johannes Zuber, Axel Schambach, Adrian Schwarzer	15
15	Cost-effectiveness of methods in personalized medicine. Results of a decision-analytic model in patients with acute myeloid leukemia with normal karyotype 2017 ·Leukemia Research ·(unknown), Richard F. Schlenk, Michael Stadler, Maria M. Gabriel, Felicitas Thol, Jan Schildmann, Jochen Vollmann, Ursula Rochau, Gaby Sroczynski, Jürgen Wasem, Arnold Ganser, Matthias Port, Anja Neumann	9
16	Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects 2015 ·Clinical Cancer Research ·Jasmin Wellbrock, (unknown), Julian Köhler, Katharina Wagner, Hauke Stamm, Eik Vettorazzi, Gabi Vohwinkel, (unknown), (unknown), (unknown), Kristoffer Riecken, Sonja Loges, Felicitas Thol, Claudia Schubert, Michael Amling, Manfred Jücker, Carsten Bokemeyer, Michael Heuser, Jürgen Krauter, Walter Fiedler	86
17	Myelodysplastische Syndrome 2015 ·Der Internist ·Felicitas Thol, Michael Heuser, Arnold Ganser	1
18	Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome 2015 ·Nature Communications ·Vikas Madan, Deepika Kanojia, Jia Li, Ryoko Okamoto, Aiko Sato‐Otsubo, Alexander Kohlmann, Masashi Sanada, Vera Großmann, Janani Sundaresan, Yuichi Shiraishi, Satoru Miyano, Felicitas Thol, Arnold Ganser, Henry Yang, Torsten Haferlach, Seishi Ogawa, H. Phillip Koeffler	173
19	Next‐generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3‐ITD or NPM1 mutations 2012 ·Genes Chromosomes and Cancer ·Felicitas Thol, (unknown), Frédérik Damm, Katarina Reinhardt, Jan‐Henning Klusmann, Dirk Reinhardt, Nils von Neuhoff, Martijn H. Brugman, Brigitte Schlegelberger, Sebastian Suerbaum, Jürgen Krauter, Arnold Ganser, Michael Heuser	95
20	Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes 2012 ·Annals of Hematology ·Felicitas Thol, Haiyang Yun, (unknown), Frédérik Damm, Eva M. Weissinger, Jürgen Krauter, Katharina Wagner, Michael Morgan, Martin Wichmann, Gudrun Göhring, Gesine Bug, Oliver G. Ottmann, Wolf‐Karsten Hofmann, Axel Schambach, Brigitte Schlegelberger, Torsten Haferlach, David Bowen, Ken Mills, Arnold Ganser, Michael Heuser	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact